Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia?
Open Access
- 15 October 1999
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 274 (1) , 37-40
- https://doi.org/10.1016/s0304-3940(99)00662-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The −491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEϵ4 allele and Alzheimer's DiseaseNeuroscience Letters, 1999
- A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's diseaseNeuroscience Letters, 1999
- The —491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimerʼs diseaseNeuroReport, 1999
- Risk for Alzheimer's disease correlates with transcriptional activity of the APOE geneHuman Molecular Genetics, 1998
- Association between bleomycin hydrolase and Alzheimer's disease in caucasiansAnnals of Neurology, 1998
- Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's diseaseHuman Molecular Genetics, 1998
- Bleomycin hydrolase is associated with risk of sporadic Alzheimer's diseaseNature Genetics, 1998
- A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementiaNature Genetics, 1998
- Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+Biological Psychiatry, 1997
- Human Bleomycin Hydrolase: Molecular Cloning, Sequencing, Functional Expression, and Enzymatic CharacterizationBiochemistry, 1996